Cytosorbents (NASDAQ: CTSO)
Cytosorbents Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cytosorbents Company Info
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Princeton, NJ.
News & Analysis
Here's Why Cytosorbents Is Up 17% Today
The biotech company took another step toward introducing a new way of performing bypass surgeries.
Why CytoSorbents Is Soaring 12% Today
The company has priced its recently announced stock offering.
Why CytoSorbents Stock Got Clobbered Today
A stock offering overshadowed the company's impressive preliminary second-quarter results.
Why Cytosorbents Corp Shares Burst Today
Cytosorbents is restructuring its sales force after delivering results that were shy of analysts targets.
Valuation
Earnings Transcripts
Cytosorbents Corp (CTSO) Q3 2020 Earnings Call Transcript
CTSO earnings call for the period ending September 30, 2020.
Cytosorbents Corp (CTSO) Q2 2020 Earnings Call Transcript
CTSO earnings call for the period ending June 30, 2020.
Cytosorbents Corp (CTSO) Q1 2020 Earnings Call Transcript
CTSO earnings call for the period ending March 31, 2020.
Cytosorbents (CTSO) Q2 2019 Earnings Call Transcript
CTSO earnings call for the period ending June 30, 2019.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.